Medical Engineering & Physics
Volume 28, Issue 7 , Pages 629-638 , September 2006

Physiological modelling of agitation–sedation dynamics including endogenous agitation reduction

  • A.D. Rudge

      Affiliations

    • Centre for Bioengineering, Department of Mechanical Engineering, University of Canterbury, Private Bag 4800, Christchurch, New Zealand
    • Corresponding Author InformationCorresponding author. Tel.: +64 21 147 5582; fax: +64 3 364 2078.
    • ,
  • J.G. Chase

      Affiliations

    • Centre for Bioengineering, Department of Mechanical Engineering, University of Canterbury, Private Bag 4800, Christchurch, New Zealand
    • ,
  • G.M. Shaw

      Affiliations

    • Department of Intensive Care Medicine, Christchurch Hospital, University of Otago School of Medicine and Health Sciences, Christchurch, New Zealand
    • ,
  • D. Lee

      Affiliations

    • Centre for Bioengineering, Department of Mathematics and Statistics, University of Canterbury, Christchurch, New Zealand

Received 18 April 2005 ,Revised 7 October 2005 ,Accepted 17 October 2005.

References 

  1. Burns AM, Shelly MP, Park GR. The use of sedative agents in critically ill patients. Drugs. 1992;43(4):507–515
  2. Kress JP, Pohlman A, O’Conner M, Hall J. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342(20):1471–1477
  3. Fraser GL, Riker RR. Advances and controversies in sedating the adult critically ill. NY Heath-Syst Pharm. 2001;20(3):17–24
  4. Smyrnios NA, Connolly A, Wilson MM, Curley FJ, French CT, Heard SO, et al. Effects of a multifaceted, multidisciplinary, hospital-wide quality improvement program on weaning from mechanical ventilation. Crit Care Med. 2002;30(6):1224–1230
  5. Szokol JW, Vender JS. Anxiety, delirium, and pain in the intensive care unit. Crit Care Clin. 2001;17(4):821–842
  6. Barr J, Donner A. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. J Crit Care Clin. 1995;11(4):827–847
  7. Brattebo G, Hofoss D, Flaatten H, Muri AK, Gjerde S, Plsek PE. Effect of a scoring system and protocol for sedation on duration of patients’ need for ventilator support in a surgical intensive care unit. BMJ. 2002;324(7350):1386–1389
  8. Smith BE, Reves JG. Computer-assisted continuous infusion of intravenous anesthesia drugs. Boston: Little, Brown and Company; 1995;
  9. Shaw GM, Dove RA, Greenfield KM, Rudge AD, Chase JG. A computerised approach to sedation administration in critically ill patients. In: Proceedings of ANZICS/ACCCN 28th Australia and New Zealand ASM on Intensive Care. Dunedin, New Zealand. 2003;
  10. Shaw GM, Chase JG, Rudge AD, Starfinger C, Lam Z, Lee D, et al. Rethinking sedation and agitation management in critical illness. Crit Care Resusc. 2003;5:109–120
  11. Weinert CR, Chlan L, Gross C. Sedating critically ill patients: factors affecting nurses’ delivery of sedative therapy. Am J Crit Care. 2001;10(3):156–165
  12. Fraser GL, Riker RR. Monitoring sedation, agitation, analgesia, and delirium in critically ill adult patients. Crit Care Clin. 2001;17(4):967–987
  13. Chase JG, Agogue F, Starfinger C, Lam Z, Shaw GM, Rudge AD, et al. Quantifying agitation in sedated ICU patients using digital imaging. J Comput Methods Prog Biomed. 2004;76(2):131–141
  14. Chase JG, Starfinger C, Lam Z, Agogue F, Shaw GM. Quantifying agitation in sedated ICU patients using heart rate and blood pressure. Physiol Meas. 2004;25:1037–1051
  15. Lam Z, Starfinger C, Chase JG, Shaw GM, Agogue F. Movement quantification for use in agitation quantification in sedated ICU patients. In: Proceedings of the World Congress on Medical Physics and Biomedical Engineering (JVC2003). Sydney, Australia. 2003;
  16. Starfinger C, Lam Z, Chase JG, Shaw GM, Agogue F. Measurement of agitation in sedated ICU patients using adaptive signal processing and fuzzy mathematics. In: Proceedings of the World Congress on Medical Physics and Biomedical Engineering (WC2003). Sydney, Australia. 2003;
  17. Chase JG, Rudge AD, Shaw GM, Wake GC, Lee D, Hudson I, et al. Modelling and control of the agitation–sedation cycle for critical care patients. Med Eng Phys. 2004;26(6):459–471
  18. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999;27(12):2609–2615
  19. Rudge AD, Chase JG, Shaw GM, Wake GC. Improved agitation management in critically ill patients via feedback control of sedation administration. In: Proceedings of the World Congress on Medical Physics and Biomedical Engineering (WC2003). Sydney, Australia, August 24–29. 2003;p. 4;ISSN: 1727–1983
  20. Rudge AD, Chase JG, Shaw GM, Johnston L, Wake GC. Modelling and control of the agitation–sedation cycle. In: Proceedings of the 5th IF AC Symposium on Modelling and Control in Biomedical Systems. Melbourne, Australia, August 21–23. 2003;p. 89–95
  21. Rudge AD, Chase JG, Shaw GM, Lee DS. Physiologically-based minimal model of agitation–sedation dynamics. In: Proceedings of the 26th International Conference of IEEE Engineering in Med. and Biology Society (EMBS 2004). San Francisco, CA, September 1–5. 2004;
  22. Chase JG, Rudge AD, Lee DS, Shaw GM. H-infinity control analysis of patient agitation management in the critically ill. Int J Intell Syst Technol Appl (IJISTA). 2004;1(1–2):111–125
  23. Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL. Response surface model for anesthetic drug interactions. Anesthesiology. 2000;92(6):1603–1616
  24. Meineke I, Freudenthaler S, Hofmann U, Schaeffeler E, Mikus G, Schwab M, et al. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Br J Clin Pharmacol. 2002;54(6):592–603
  25. Andersen G, Christrup L, Sjogren P. Relationships among morphine metabolism, pain and side effects during long-term treatment: an update. J Pain Symptom Manage. 2003;25(1):74–91
  26. Bates JJ, Foss JF, Murphy DB. Are peripheral opioid antagonists the solution to opioid side effects?. Anesth Analg. 2004;98(1):116–122
  27. Lotsch J, Skarke C, Schmidt H, Liefhold J, Geisslinger G. Pharmacokinetic modelling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers. Clin Pharmacol Ther. 2002;72(2):151–162
  28. Faura CC, Collins SL, Moore RA, McQuay HJ. Systematic review of factors affecting the ratios of morphine and its major metabolites. Pain. 1998;74(1):43–53
  29. Milne RW, Nation RL, Somogyi AA. The disposition of morphine and its 3-and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab Rev. 1996;28(3):345–472
  30. Platten HP, Schweizer E, Dilger K, Mikus G, Klotz U. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. Clin Pharmacol Ther. 1998;63(5):552–560
  31. Persson P, Nilsson A, Hartvig P, Tamsen A. Pharmacokinetics of midazolam in total I.V. anaesthesia. Br J Anaesth. 1987;59(5):548–556
  32. Bolon M, Bastien O, Flamens C, Paulus S, Salord F, Boulieu R. Evaluation of the estimation of midazolam concentrations and pharmacokinetic parameters in intensive care patients using a bayesian pharmacokinetic software (PKS) according to sparse sampling approach. J Pharm. Pharmacol. 2003;55(6):765–771
  33. Bauer TM, Ritz R, Haberthur C, Ha HR, Hunkeler W, Sleight AJ, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet. 1995;346(8968):145–147
  34. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med. 1998;26(5):947–956
  35. Tuk B, van Oostenbruggen MF, Herben VM, Mandema JW, Danhof M. Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam. J Pharmacol Exp Ther. 1999;289(2):1067–1074
  36. Young C, Knudsen N, Hilton A, Reves JG. Sedation in the intensive care unit. Crit Care Med. 2000;28(3):854–866
  37. Oldenhof H, de Jong M, Steenhoek A, Janknegt R. Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability?. Clin Pharmacol Ther. 1988;43(3):263–269
  38. Vinik HR, Reves J, Greenblatt D, Abernethy D, Smith L. The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology. 1983;59(5):390–394
  39. Albrecht S, Ihmsen H, Hering W, Geisslinger G, Dingemanse J, Schwilden H, et al. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther. 1999;65(6):630–639
  40. Levine RL. Pharmacology of intravenous sedatives and opioids in critically ill patients. Crit Care Clin. 1994;10(4):709–731
  41. Wagner BK, O’Hara D. Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients. Clin Pharmacokinet. 1997;33(6):426–453
  42. De Jonghe B, Cook D, Griffith L, Appere-de-Vecchi C, Guyatt G, Theron V, et al. Adaptation to the intensive care environment (ATICE):development and validation of a new sedation assessment instrument. Crit Care Med. 2003;31(9):2344–2354
  43. Romberg R, Olofsen E, Sarton E, den Hartigh J, Taschner PE, Dahan A. Pharmacokinetic-pharmacodynamic modelling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences. Anesthesiology. 2004;100(1):120–133
  44. Koopmans R, Dingemanse J, Danhof M, Horsten GP, van Boxtel CJ. Pharmacokinetic-pharmacodynamic modelling of midazolam effects on the human central nervous system. Clin Pharmacol Ther. 1988;44(1):14–22
  45. Carlson N. Physiology of behaviour. eighth ed.. Boston: Allyn and Bacon; 2001;
  46. Guyton AC, Hall JE. Textbook of medical physiology. ninth ed.. London: W.B. Saunders Company; 1996;
  47. Hann CE, Chase JG, Lin J, Lotz T, Doran CV, Shaw GM. Integral-based parameter identification for long-term dynamic verification of a glucose–insulin system model. J Comput Methods Prog Biomed. 2005;77(3):259–270
  48. Helson H. Psychology: a study of a science. 1. New York: McGraw-Hill; 1959;
  49. Greenfield KM, Dove RA, Shaw GM. Optimisation of sedation therapy within an intensive care setting. In: Proceedings of the Engineering and Physical Sciences in Medicine. Fremantle, Australia. 2001;
  50. Wand MP, Jones MC. Kernel smoothing. Monographs on statistics and applied probability. London: Chapman & Hall; 1995;
  51. Hardle W. Applied nonparametric regression. Cambridge: Cambridge University Press; 1990;
  52. Lee DS, Rudge AD, Chase JG, Shaw GM, Johnston L, Wake GC. Dynamic model assessment using a probability band for local linear kernel regression, with an application in agitation–sedation modelling. In: Proceedings of New Zealand Statistical Association 54th Annual Conference, Massey University. Palmerston North. 2003;
  53. Rudge AD, Chase JG, Shaw GM, Lee DS. Physiological modelling of agitation–sedation dynamics. Med Eng Phys, in press.
  54. Lee DS, Rudge AD, Chase JG, Shaw GM. A new model validation tool using kernel regression and density estimation. J Comput Methods Prog Biomed. 2005;80(1):75–87
  55. Chase JG, Shaw GM, Lin J, Doran CV, Hann CE, Robertson MB, et al. Adaptive bolus-based targeted glucose regulation of hyperglycaemia in critical care. Med Eng Phys. 2005;27(1):1–11ISSN: 1350–4533
  56. Arbour R. Sedation and pain management in critically ill adults. Crit Care Nurs. 2000;20(5):39–56
  57. Efron B, Tibshirani R. An Introduction to the bootstrap. London: Chapman & Hall; 1993.

PII: S1350-4533(05)00221-3

doi: 10.1016/j.medengphy.2005.10.008

Medical Engineering & Physics
Volume 28, Issue 7 , Pages 629-638 , September 2006

Article Tools

* Image Usage & Resolution